CVS Settles US Opioid Lawsuit for $315 Million

CVS Health agreed to pay $315 million to resolve US Justice Department allegations that it unlawfully filled unnecessary opioid prescriptions. The company denied wrongdoing as part of the settlement.

Xurve View
Insights:
FILE PHOTO: People walk by a CVS pharmacy store in Manhattan, New York City, New York in this illustration, U.S., November 17, 2021. REUTERS/Andrew Kelly/File photo

CVS HEALTH CORP agreed to pay $315 million to resolve allegations of unlawfully filling unnecessary opioid prescriptions, the United States Justice Department said on Tuesday. The settlement resolves a 2024 whistleblower lawsuit holding the pharmacy chain responsible for dispensing addictive painkillers during the nationwide opioid epidemic. The resolution follows a similar $50 million agreement reached in August with rival retailer WALMART INC over opioid dispensing practices.

IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.